Wolverine Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Wolverine Asset Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$170K	–	1867
2018 Q3	$170K	Hold	50,000	–	–	﹤0.01%	1213
2018 Q2	$188K	Hold	50,000	–	–	﹤0.01%	1112
2018 Q1	$204K	Hold	50,000	–	–	﹤0.01%	1145
2017 Q4	$232K	Hold	50,000	–	–	﹤0.01%	1059
2017 Q3	$355K	Hold	50,000	–	–	﹤0.01%	894
2017 Q2	$361K	Buy	+50,000	New	+$312K	﹤0.01%	852
2016 Q1	–	Sell	-61	Closed	-$18K	–	1779
2015 Q4	$18K	Sell	61 -45	-42%	-$214	﹤0.01%	1340
2015 Q3	$34K	Sell	106 -1,000	-90%	-$6.7K	﹤0.01%	1360
2015 Q2	$133K	Buy	+1,106	New	+$11.9K	﹤0.01%	1030
2014 Q4	–	Sell	-75	Closed	-$5K	–	2650
2014 Q3	$5K	Buy	+75	New	+$1.15K	﹤0.01%	2158

Wolverine Asset Management's KERX Position: Q4 2018 in Review

Wolverine Asset Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 47,895 shares — an estimated $162K sold.

Wolverine Asset Management first reported a position in KERX in Q2 2013 and held it in 17 quarters. The position peaked at $502K in Q2 2015. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Wolverine Asset Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Wolverine Asset Management sold 47,895 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $162K.
Wolverine Asset Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 17 quarters.
Wolverine Asset Management's Keryx Biopharmaceuticals Inc position peaked at $502K in Q2 2015.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Wolverine Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.